Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000698280 | SCV000826936 | benign | Neurofibromatosis, type 1 | 2024-11-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002440494 | SCV002680594 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2021-03-31 | criteria provided, single submitter | clinical testing | The p.H2786Q variant (also known as c.8358C>A), located in coding exon 57 of the NF1 gene, results from a C to A substitution at nucleotide position 8358. The histidine at codon 2786 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV003460953 | SCV004198329 | uncertain significance | Juvenile myelomonocytic leukemia | 2023-09-05 | criteria provided, single submitter | clinical testing |